Peptides for Testosterone: Managing Side Effects and Optimizing Outcomes

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

Common TRT side effects include erythrocytosis (elevated hematocrit), acne, hair loss, testicular atrophy, and mood changes. Most are manageable with dose adjustment, injection frequency optimization, and targeted interventions. Erythrocytosis (hematocrit >54%) is the most clinically significant side effect requiring immediate attention.

Managing TRT Side Effects

Testosterone replacement therapy is generally well-tolerated, but like all medical interventions, it can produce side effects that require management. Understanding the common side effects, their mechanisms, and effective management strategies allows patients and clinicians to optimize TRT outcomes while minimizing adverse effects.

Erythrocytosis (Elevated Hematocrit)

Erythrocytosis — an increase in red blood cell mass and hematocrit — is the most clinically significant side effect of TRT. Testosterone stimulates erythropoiesis (red blood cell production) through multiple mechanisms, including stimulation of erythropoietin production. Elevated hematocrit increases blood viscosity and thrombotic risk. Management: monitor hematocrit every 3–6 months. If hematocrit exceeds 54%, options include dose reduction, more frequent smaller injections (which reduce peak testosterone levels), therapeutic phlebotomy (blood donation), and switching to a transdermal formulation (which produces lower peak testosterone levels).

Acne

Acne is a common side effect of TRT, particularly in the first few months of therapy. It is driven by testosterone's stimulation of sebaceous glands and is more common in men who are prone to acne. Management: topical retinoids (tretinoin), benzoyl peroxide, and salicylic acid are first-line treatments. Dose reduction may be necessary in severe cases. Switching to a more frequent injection schedule (every 3.5 days) reduces peak testosterone levels and may reduce acne severity.

Hair Loss

TRT can accelerate androgenetic alopecia (male pattern baldness) in genetically predisposed men, as DHT (a testosterone metabolite) drives hair follicle miniaturization. Management: finasteride (1 mg daily) blocks the conversion of testosterone to DHT and can prevent TRT-induced hair loss. Topical minoxidil can also be added. GHK-Cu topical application may help preserve hair follicle health.

Testicular Atrophy

TRT suppresses the HPG axis, reducing LH and FSH, which causes testicular atrophy. Management: HCG (500 IU every other day) or gonadorelin (100 mcg twice daily) maintains intratesticular testosterone production and prevents testicular atrophy.

Mood Changes

Some men experience mood changes on TRT — irritability, anxiety, or mood swings — particularly in the first few months or when doses are too high. Management: dose reduction, more frequent injections (for more stable levels), and estrogen management (if mood changes are associated with elevated estradiol) are the primary approaches.